Dean H. Stanton · Selected Work
HCPCS / PDAC Coding, Application & Reconsideration Governance
A sustained medical-product market-access program connecting HCPCS research, PDAC applications, product evidence, executive authorization, DMECS maintenance, adverse-decision review, and controlled reconsideration across an orthopedic portfolio.
Results
Results and contributions.
01
Situation
Operating context
PPI needed defensible HCPCS classification across a broad orthopedic portfolio while keeping product evidence, submissions, samples, decisions, product consistency, DMECS records, and commercial information synchronized.
02
Challenge
What made the work difficult
A coding decision affects product market access but is not the same as insurance coverage or guaranteed reimbursement. Applications had to align product evidence, variants, deadlines, decisions, reconsiderations, and product-data changes across teams.
03
Dean's role
Responsibility and authority
Dean provided executive sponsorship and direct participation in coding research, application and reconsideration management, product-evidence coordination, executive authorization, decision tracking, and the response to classification changes across the portfolio.
04
Actions
How the work moved forward
- Governed HCPCS and PDAC product-scoping, evidence-package, and submission workflows across multiple product families.
- Coordinated product information, literature, identifiers, samples, executive authorization, and decision tracking.
- Managed adverse-decision review and reconsideration cycles as controlled product-realization work rather than isolated paperwork.
- Maintained alignment among coding decisions, DMECS/product-classification records, product data, and commercial communications.